These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25053823)

  • 1. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma.
    Balbous A; Renoux B; Cortes U; Milin S; Guilloteau K; Legigan T; Rivet P; Boissonnade O; Martin S; Tripiana C; Wager M; Bensadoun RJ; Papot S; Karayan-Tapon L
    Mol Cancer Ther; 2014 Sep; 13(9):2159-69. PubMed ID: 25053823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma.
    Hamon F; Renoux B; Chadéneau C; Muller JM; Papot S
    Eur J Med Chem; 2010 Apr; 45(4):1678-82. PubMed ID: 20116904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
    Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
    Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
    Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
    Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway.
    Carballo GB; Matias D; Ribeiro JH; Pessoa LS; Arrais-Neto AM; Spohr TCLSE
    Life Sci; 2020 Sep; 257():118027. PubMed ID: 32622951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.
    Bensalma S; Chadeneau C; Legigan T; Renoux B; Gaillard A; de Boisvilliers M; Pinet-Charvet C; Papot S; Muller JM
    J Mol Neurosci; 2015 Jan; 55(1):51-61. PubMed ID: 25280457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
    El Khatib M; Kalnytska A; Palagani V; Kossatz U; Manns MP; Malek NP; Wilkens L; Plentz RR
    Hepatology; 2013 Mar; 57(3):1035-45. PubMed ID: 23172661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.
    Eimer S; Dugay F; Airiau K; Avril T; Quillien V; Belaud-Rotureau MA; Belloc F
    Neuro Oncol; 2012 Dec; 14(12):1441-51. PubMed ID: 23104476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.
    Zhou Y; Yang J; Kopeček J
    Biomaterials; 2012 Feb; 33(6):1863-72. PubMed ID: 22138033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
    Ferruzzi P; Mennillo F; De Rosa A; Giordano C; Rossi M; Benedetti G; Magrini R; Pericot Mohr Gl; Miragliotta V; Magnoni L; Mori E; Thomas R; Tunici P; Bakker A
    Int J Cancer; 2012 Jul; 131(2):E33-44. PubMed ID: 22072503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
    Feldmann G; Fendrich V; McGovern K; Bedja D; Bisht S; Alvarez H; Koorstra JB; Habbe N; Karikari C; Mullendore M; Gabrielson KL; Sharma R; Matsui W; Maitra A
    Mol Cancer Ther; 2008 Sep; 7(9):2725-35. PubMed ID: 18790753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.
    Kumar SK; Roy I; Anchoori RK; Fazli S; Maitra A; Beachy PA; Khan SR
    Bioorg Med Chem; 2008 Mar; 16(6):2764-8. PubMed ID: 18249125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
    Gould A; Missailidis S
    Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
    Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice.
    Sanchez P; Ruiz i Altaba A
    Mech Dev; 2005 Feb; 122(2):223-30. PubMed ID: 15652709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
    Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
    Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
    Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
    Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells.
    Nanta R; Shrivastava A; Sharma J; Shankar S; Srivastava RK
    Mol Cell Biochem; 2019 Apr; 454(1-2):11-23. PubMed ID: 30251117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.